Skip to content

Study of Ayurvedic medicine Ervarubijadi Yoga in the management of Pittaj Mutrakrucchra.

Randomized controlled clinical study to evaluate the efficacy of Ervarubijadi Yoga in the management of Pittaj Mutrakrucchra in children with special reference to lower urinary tract infection. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074436
Enrollment
80
Registered
2024-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z00-Z99- Factors influencing health status and contact with health services

Interventions

Intervention1: ERVARUBIJADI YOGA: 5 to 12 gm in 3 divided doses with Tandulodak oral for 7 days Intervention2: NIL: NIL Control Intervention1: SHRUNGATAK HEEM: 20 - 30 Ml shrungatak heem in 3 divided

Sponsors

Dr Ankita Ramkrushna Bobade
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children of age group 6 years-16 years. 2. Patients irrespective of gender, caste, socioeconomic status. 3. Patients with classical signs and symptoms of pittaj mutrakrucchra sadah, saruja, muhurmuhu mutrapravritti etc. 4. Only those patients will be selected whose parents are willing to give written consent.

Exclusion criteria

Exclusion criteria: 1. Patients below 6 years and above 16 years. 2. All other types of Mutrakrucchra except Pittaj. 3. Patients with congenital abnormalities and other systemic diseases.

Design outcomes

Primary

MeasureTime frame
Dysuria,Burning Micturition,Frequent UrinationTimepoint: Baseline 1st, 4th and 7th day

Secondary

MeasureTime frame
No. of pus cells, no. of RBCs, pH OF urineTimepoint: Baseline 1st, 4th, 7th day

Countries

India

Contacts

Public ContactDr Kavita Fadnavis

Chhatrapati Shahu Maharaj Shikshan Sanstha Ayurved Mahavidyalaya, Aurangabad

dr.kavitafadnavis@gmail.com9172933561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026